Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiania, Brazil

被引:26
作者
Andrade, Ana Lucia [2 ]
Oliveira, Renato [2 ]
Vieira, Maria A. [2 ]
Minamisava, Ruth [3 ]
Pessoa, Vicente, Jr. [2 ]
Brandileone, Maria Cristina C. [4 ]
Alves, Sueli L. A. [5 ]
Alfieri, Fernando [6 ]
Pagliarini, Rosana [6 ]
Moraes, Jose Cassio [7 ]
Gray, Sharon [1 ]
Rodgers, Gail L. [1 ]
机构
[1] Pfizer Inc, Collegeville, PA 19426 USA
[2] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil
[3] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil
[4] Adolfo Lutz Inst, Sao Paulo, Brazil
[5] Secretariat Hlth Goias State, Goiania, Go, Brazil
[6] Pfizer Inc, Sao Paulo, Brazil
[7] Santa Casa Sch Med Sci, Sao Paulo, Brazil
关键词
Streptococcus pneumoniae; Pneumococcal infections; Pneumococcal pneumonia; Population-based incidence; Pneumococcal conjugate vaccines; COMMUNITY-ACQUIRED PNEUMONIA; PLACEBO-CONTROLLED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; HOSPITALIZED CHILDREN; CHILDHOOD PNEUMONIA; DOUBLE-BLIND; INFECTIONS; SEROTYPES; INFLUENZA;
D O I
10.1016/j.vaccine.2011.12.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Background: Streptococcus pneumoniae is the leading cause of vaccine-preventable death in children <5 years of age globally. We determined incidence rates of invasive pneumococcal disease (IPD), clinical and chest X-ray-confirmed pneumonia (CXR + Pn), S. pneumoniae serotype distribution, and antimicrobial susceptibility in children in Goiania, Brazil. Methods: Prospective, population-based surveillance was conducted from May 2007 to May 2009 in children 28 days to <36 months of age presenting to all 33 pediatric healthcare services (outpatient departments, emergency rooms, hospitals) in Goiania. Eligibility criteria were temperature >= 39.0 degrees C in the previous 24 h and/or clinical suspicion of pneumonia or IPD. Results: 14,509 subjects were enrolled. Median age was 14.0 months. S. pneumoniae was detected in 64 samples from 62 subjects: 58(90.6%) blood; 4(6.3%) cerebrospinal fluid; and 2(3.1%) pleural fluid. Incidence rate of IPD (culture- and polymerase chain reaction-positive) for all children aged 28 days to <36 months was 57.5/100,000; overall incidence for culture-positive only was 54.9/100,000. Age stratification of culture-positive-only subjects found the highest rates were, 114.6/100,000 and 69.8/100,000, respectively, for the 6 months to <12 months and 12 months to <24 months age groups. The overall incidence of invasive pneumonia and pneumococcal meningitis was 37.2/100,000 and 5.3/100,000, respectively. The most common IPD serotypes were 14(45.0%), 6B (13.3%). 18C (6.7%), and 23F(5.0%). Eight isolates (13.3%) were penicillin nonsusceptible. The cumulative percentages of serotypes included in 7-valent, 10-valent, and 13-valent pneumococcal conjugate vaccines were 78.3%, 80.0%, and 88.3%, respectively. The overall incidence of clinical pneumonia and CXR+Pn was, 9598/100,000 and 3428/100,000, respectively. CXR+ Pn rates for hospitalized and non-hospitalized subjects were 1751/100,000 and 1677/100,000, respectively. Conclusions: The burden of IPD and pneumonia is considerable in children in a large Brazilian city, and is seen in hospitalized as well as ambulatory subjects. Vaccination with pneumococcal conjugate vaccines has the potential to decrease this burden. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1901 / 1909
页数:9
相关论文
共 45 条
[1]
Abarca K, 2008, REV CHIL INFECTOL, V25, P97, DOI /S0716-10182008000300001
[2]
Andrade Ana Lúcia Sampaio Sgambatti de, 2004, Cad. Saúde Pública, V20, P411, DOI 10.1590/S0102-311X2004000200008
[3]
[Anonymous], 2010, Population Census
[4]
Distribution of Streptococcus pneumoniae serotypes in nasopharyngeal carriage and in invasive pneumococcal disease in Sao Paulo, Brazil [J].
Berezin, Eitan N. ;
Cardenuto, Maria D. ;
Ferreira, Leda L. ;
Otsuka, Marcelo ;
Guerra, Maria L. ;
Brandileone, Maria Cristina C. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (07) :643-645
[5]
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[6]
Streptococcus pneumoniae colonisation:: the key to pneumococcal disease [J].
Bogaert, D ;
de Groot, R ;
Hermans, PWM .
LANCET INFECTIOUS DISEASES, 2004, 4 (03) :144-154
[7]
Brandileone MCD, 1997, MICROB DRUG RESIST, V3, P141
[8]
Brazilian Ministry of Health, DAT INF SAUD
[9]
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness [J].
Brundage, JF .
LANCET INFECTIOUS DISEASES, 2006, 6 (05) :303-312
[10]
Revisiting Pneumococcal Carriage by Use of Broth Enrichment and PCR Techniques for Enhanced Detection of Carriage and Serotypes [J].
Carvalho, Maria da Gloria ;
Pimenta, Fabiana C. ;
Jackson, Delois ;
Roundtree, Alexis ;
Ahmad, Yusra ;
Millar, Eugene V. ;
O'Brien, Katherine L. ;
Whitney, Cynthia G. ;
Cohen, Adam L. ;
Beall, Bernard W. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) :1611-1618